Takeda California Inc.
Division of Takeda Pharmaceutical Co. Ltd.
Latest From Takeda California Inc.
Sea Lane Biotechnologies LLC’s original goal was to leverage the immunological repertoire of flu epidemic survivors by harvesting bone marrow and screening for natural antibodies that could then be developed into drugs, but the human-derived antibodies that Sea Lane gathered in its early days contributed to a new technology platform. Sea Lane thinks its technology, called ConCIRT, for Contextual Immune Repertoire Technology, will prove capable of generating novel treatments for cancer and potentially other non-infectious diseases.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
Derived from Strategic Transactions, EBI’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals– and then categorized by type –Acquisition, Alliance, or Financing.
With the acquisition of Nycomed, Takeda’s long-standing strategy for becoming a world-class pharma has come into focus. The company spent much of the past decade building up its pipeline, globalizing R&D and importing Western staff, assets, platforms and processes. It also began a hectic period of M&A unparalleled among Japanese companies, culminating in 2011 with its acquisition of Nycomed. Now its focus will need to shift from big acquisitions and organizational makeover to execution.
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Metabolic Disorders
- Syrrx Inc.
- North America
- Parent & Subsidiaries
- Takeda Pharmaceutical Co. Ltd.
- Senior Management
Keith P Wilson, PhD, Pres. & CSO
Umi Chong, Sr. Dir., Fin.
- Contact Info
Takeda California Inc.
Phone: (858) 622-8528
10410 Science Center Dr.
San Diego, CA 92121
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.